TrialBMC cancer2021

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study.

Lucheng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.